Dynavax
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.About DVAX
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
DVAX Key Statistics
Stock Snapshot
With a market cap of 1.29B, Dynavax(DVAX) trades at $10.96. The stock has a price-to-earnings ratio of -28.70.
On 2025-12-04, Dynavax(DVAX) stock moved within a range of $10.79 to $11.03. With shares now at $10.96, the stock is trading +1.6% above its intraday low and -0.6% below the session's peak.
Trading volume for Dynavax(DVAX) stock has reached 1.48M, versus its average volume of 1.7M.
Over the past 52 weeks, Dynavax(DVAX) stock has traded between a high of $14.63 and a low of $9.20.
Over the past 52 weeks, Dynavax(DVAX) stock has traded between a high of $14.63 and a low of $9.20.
DVAX News
In trading on Monday, shares of Dynavax Technologies Corp (Symbol: DVAX) crossed below their 200 day moving average of $10.99, changing hands as low as $10.65 p...
Shares of Moderna (MRNA) and other vaccine stocks tumbled Monday after a Food and Drug Administration director reportedly issued a memo that says Covid shots ki...
